Adapting Traditional Drug Development Methods for Epigenetic Therapies- Peter Staller
Peter Staller Director of Oncology Research at Epitherapeutics talks to Pharma IQ about the differences between traditional drug development techniques and those required for development of a epigenetic therapy. He also discusses epigenetics as a growing area for finding druggable targets and the maturity of the field.
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.